11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
Now that the calendar has flipped to 2020, planning and fundraising efforts are intensifying in adva...
Read More >
Staffing Agency Allowed Sexual Abuse of Several Women Placed in Jobs at Albuquerque Police Unit, Fed...
Read More >
On August 12, 2019, the National Labor Relations Board (“NLRB” or the “Board”) published propose...
Read More >
On September 24, 2019, the DOL announced new rules regarding the salary requirement for exempt emplo...
Read More >
As the Novel-Coronavirus (“COVID-19”) continues to cause disruption to every aspect of society, th...
Read More >
It's the end of the year and while everyone is busy, employers in California should be aware of new ...
Read More >